Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER database

Background: Lung adenocarcinoma (ADC) is the main cause of death related to lung cancer. The aim of this study was to identify poor prognostic factors for overall survival (OS) in patients with stage IV lung ADC in real-world clinical practice. Methods: Patients were selected from the Surveillance E...

Descripción completa

Detalles Bibliográficos
Autores: Campos-Balea, Begoña; de Castro Carpeño, Javier; Massutí, Bartomeu; Vicente-Baz, David; Pérez Parente, Diego; Ruiz-Gracia, Pedro; Crama, Leonardo; Cobo Dols, Manuel
Tipo de documento: Artículo
Fecha de publicación:2020
País:España
Institución:Instituto de Salud Carlos III (ISCIII)
Repositorio:Repisalud
Lenguaje:Inglés
OAI Identifier:oai:repisalud.isciii.es:20.500.12105/17983
Acceso en línea:http://hdl.handle.net/20.500.12105/17983
Nivel de acceso:Acceso abierto
Palabra clave:Lung adenocarcinoma
Metastasis
Non-small cell lung cancer
Overall survival
Prognostic factor
Adenocarcinoma del pulmón
Metástasis neoplásica
Carcinoma de pulmón de células no pequeñas
Pronóstico
Lung
Aged
Female
Humans
Male
Neoplasm Metastasis
Prognosis
SEER Program
Adenocarcinoma
Lung Neoplasms
Liver Neoplasms
_version_ 1878736989948215296
author Campos-Balea, Begoña
author2 de Castro Carpeño, Javier
Massutí, Bartomeu
Vicente-Baz, David
Pérez Parente, Diego
Ruiz-Gracia, Pedro
Crama, Leonardo
Cobo Dols, Manuel
author2_role author
author
author
author
author
author
author
author_browse Campos-Balea, Begoña
Cobo Dols, Manuel
Crama, Leonardo
Massutí, Bartomeu
Pérez Parente, Diego
Ruiz-Gracia, Pedro
Vicente-Baz, David
de Castro Carpeño, Javier
author_facet Campos-Balea, Begoña
de Castro Carpeño, Javier
Massutí, Bartomeu
Vicente-Baz, David
Pérez Parente, Diego
Ruiz-Gracia, Pedro
Crama, Leonardo
Cobo Dols, Manuel
author_role author
collection Repisalud
description Background: Lung adenocarcinoma (ADC) is the main cause of death related to lung cancer. The aim of this study was to identify poor prognostic factors for overall survival (OS) in patients with stage IV lung ADC in real-world clinical practice. Methods: Patients were selected from the Surveillance Epidemiology and End Results (SEER) database. Chi-square bivariate analysis was used for the association of binary qualitative variables. A multivariate Cox regression analysis was performed to determine the impact of these prognostic factors on OS. Results: A total of 46 030 patients were included (51.3% men, mean age 67.03 ± 11.6), of whom 41.3% presented with metastases in bone, 28.9% in brain, 17.1% in liver and 31.8% in lung. Patients with liver metastases presented with two or more metastatic sites more frequently than patients without liver metastases (P < 0.001). Male sex (HR 0.78, 95% CI: 0.76-0.80), age ≥ 65 years (HR 1.37, 95% CI: 1.33-1.40), lack of family support (HR 0.80, 95% CI: 0.78-0.81) and presence of liver (HR 1.45, 95% CI: 1.40-1.50), bone (HR 1.21, 95% CI: 1.18-1.24) or brain metastases (HR 1.18, 95% CI: 1.15-1.21) were identified as poor prognostic factors for OS. Patients with liver metastasis showed the highest hazard ratio value (P < 0.001). Conclusions: The presence of liver metastases was the worst prognostic factor for patients with metastatic lung ADC. This factor should be considered as a stratification factor for future studies evaluating new cancer treatments including immunotherapy.
eu_rights_str_mv openAccess
format article
id ES_98a3f1f91e8d9d61bb7a712ae850a19b
institution Instituto de Salud Carlos III (ISCIII)
instname_str Instituto de Salud Carlos III (ISCIII)
language eng
network_acronym_str ES
network_name_str España
oai_identifier_str oai:repisalud.isciii.es:20.500.12105/17983
publishDate 2020
publishDateSort 2020
publisher China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
publisherStr China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
reponame_str Repisalud
spelling Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER database Campos-Balea, Begoña de Castro Carpeño, Javier Massutí, Bartomeu Vicente-Baz, David Pérez Parente, Diego Ruiz-Gracia, Pedro Crama, Leonardo Cobo Dols, Manuel Lung adenocarcinoma Metastasis Non-small cell lung cancer Overall survival Prognostic factor Adenocarcinoma del pulmón Metástasis neoplásica Carcinoma de pulmón de células no pequeñas Pronóstico Lung Aged Female Humans Male Neoplasm Metastasis Prognosis SEER Program Adenocarcinoma Lung Neoplasms Liver Neoplasms Background: Lung adenocarcinoma (ADC) is the main cause of death related to lung cancer. The aim of this study was to identify poor prognostic factors for overall survival (OS) in patients with stage IV lung ADC in real-world clinical practice. Methods: Patients were selected from the Surveillance Epidemiology and End Results (SEER) database. Chi-square bivariate analysis was used for the association of binary qualitative variables. A multivariate Cox regression analysis was performed to determine the impact of these prognostic factors on OS. Results: A total of 46 030 patients were included (51.3% men, mean age 67.03 ± 11.6), of whom 41.3% presented with metastases in bone, 28.9% in brain, 17.1% in liver and 31.8% in lung. Patients with liver metastases presented with two or more metastatic sites more frequently than patients without liver metastases (P < 0.001). Male sex (HR 0.78, 95% CI: 0.76-0.80), age ≥ 65 years (HR 1.37, 95% CI: 1.33-1.40), lack of family support (HR 0.80, 95% CI: 0.78-0.81) and presence of liver (HR 1.45, 95% CI: 1.40-1.50), bone (HR 1.21, 95% CI: 1.18-1.24) or brain metastases (HR 1.18, 95% CI: 1.15-1.21) were identified as poor prognostic factors for OS. Patients with liver metastasis showed the highest hazard ratio value (P < 0.001). Conclusions: The presence of liver metastases was the worst prognostic factor for patients with metastatic lung ADC. This factor should be considered as a stratification factor for future studies evaluating new cancer treatments including immunotherapy. China Lung Oncology Group and John Wiley & Sons Australia, Ltd. http://hdl.handle.net/20.500.12105/17983
spellingShingle Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER database
Campos-Balea, Begoña
Lung adenocarcinoma
Metastasis
Non-small cell lung cancer
Overall survival
Prognostic factor
Adenocarcinoma del pulmón
Metástasis neoplásica
Carcinoma de pulmón de células no pequeñas
Pronóstico
Lung
Aged
Female
Humans
Male
Neoplasm Metastasis
Prognosis
SEER Program
Adenocarcinoma
Lung Neoplasms
Liver Neoplasms
title Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER database
title_full Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER database
title_fullStr Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER database
title_full_unstemmed Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER database
title_short Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER database
title_sort Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER database
topic Lung adenocarcinoma
Metastasis
Non-small cell lung cancer
Overall survival
Prognostic factor
Adenocarcinoma del pulmón
Metástasis neoplásica
Carcinoma de pulmón de células no pequeñas
Pronóstico
Lung
Aged
Female
Humans
Male
Neoplasm Metastasis
Prognosis
SEER Program
Adenocarcinoma
Lung Neoplasms
Liver Neoplasms
topic_facet Lung adenocarcinoma
Metastasis
Non-small cell lung cancer
Overall survival
Prognostic factor
Adenocarcinoma del pulmón
Metástasis neoplásica
Carcinoma de pulmón de células no pequeñas
Pronóstico
Lung
Aged
Female
Humans
Male
Neoplasm Metastasis
Prognosis
SEER Program
Adenocarcinoma
Lung Neoplasms
Liver Neoplasms
url http://hdl.handle.net/20.500.12105/17983